Low dose local anaesthetic and fentanyl epidural solutions are commonly 'topped-up' for urgent caesarean section. However, the block characteristics associated with newer local anaesthetics such as ropivacaine 0.75% and levobupivacaine 0.5% have not been fully determined. In a randomised double-blinded controlled clinical trial, we compared 2% lignocaine with adrenaline and fentanyl (LAF), 0.75% ropivacaine and 0.5% levobupivacaine for extension of low dose epidural analgesia for urgent caesarean section in 90 Asian parturients.
Continuous infusion epidural analgesia is used commonly during labour. The epidural catheter may be used to extend an existing block for urgent caesarean section. The solution employed is usually based on the degree of urgency and the personal preference of the attending anaesthetist. Additives such as bicarbonate, adrenaline and opioids like fentanyl can enhance the blockade 1,2 . However, mixing drugs in the emergency situation may result in medication errors and delay the administration of local anaesthetic.
In a recent survey of United Kingdom anaesthetists, lignocaine 2% (alone or in combination) was administered by 40% of respondents, while levobupivacaine or bupivacaine were used by 72% of respondents 3 . A mixture of 2% lignocaine with adrenaline 1:200,000 and fentanyl 50 µg (LAF) does not significantly decrease the time to T7 block when compared to 0.5% bupivacaine, but has not been previously compared to levobupivacaine 0.5% 4 . Ropivacaine 0.75% has also been compared to 0.5% bupivacaine and does not differ in the time to achieve T4 block 5 . However, 0.75% ropivacaine has not been previously been compared with 0.5% levobupivacaine. Ropivacaine and levobupivacaine have been developed to enhance the safety of epidural anaesthesia, following evidence of bupivacainerelated toxicity. Being pure levo-isomers, they have less toxicity than racemic bupivacaine 6 . This is important when using high doses to extend epidural block, when the risk of systemic toxicity related to either overdosing or unwanted intravascular injection is significant.
The aim of this study was to evaluate the efficacy of 0.75% ropivacaine and 0.5% levobupivacaine when used to extend labour epidural analgesia for urgent caesarean section. We investigated as the primary outcome the time to surgical readiness, defined as the time to reach T4 sensory block to loss of cold sensation. Our secondary aims were to determine the incidence of intraoperative pain and the duration of block. We hypothesised that single drug therapy using ropivacaine or levobupivacaine alone would produce a similar time to surgical readiness and a longer duration of sensory block than LAF.
MATERIALS AND METHODS
This double-blind, randomised clinical trial received local research Ethics Committee approval. We included term parturients who had had epidural analgesia established via a combined spinal-epidural technique using intrathecal ropivacaine 2 mg and fentanyl 15 µg. The subjects had a well functioning epidural catheter (defined as requiring two or fewer intrapartum epidural supplements with 0.2% ropivacaine) while receiving a continuous infusion of 0.1% ropivacaine and fentanyl 2 µg/ml at 10 ml/h. The incidence of intrapartum supplementation and the time of last supplementation prior to caesarean section were recorded. Exclusion criteria were epidural intrapartum supplementation less than two hours from caesarean section or intramuscular pethidine injection within four hours, preterm labour, cardiac disease, pre-eclampsia, antepartum haemorrhage, multiple pregnancy and emergency caesarean section. Written informed consent was obtained only after effective labour analgesia had been established.
When the decision to perform an urgent caesarean section was made, the subjects were randomly allocated using a computer-generated random number in a sealed opaque envelope to receive one of three approaches for extending the epidural block, namely using a mixture of 2% lignocaine with adrenaline 1:200,000 and fentanyl 50 µg, 0.75% ropivacaine or 0.5% levobupivacaine.
On arrival at the operating theatre, the subject was placed in the supine position with left lateral tilt and monitoring was established (non-invasive right brachial artery automated blood pressure measurement, electrocardiography, pulse oximetry). The level of pre-existing block to cold sensation was assessed using ice and motor block was recorded using a modified Bromage score (0=able to straight leg raise, 1=able to raise knee and ankle, 2=able to flex ankle only, 3=unable to move legs). An intravenous infusion of Hartmann's solution 500 ml was given while the block was extended. The local anaesthetic solution was freshly prepared by an investigator. The attending anaesthetist who injected this study solution was blinded to the assignment and assessed the block characteristics subsequently.
A 15 ml volume of study solution was administered over three minutes and block height was assessed at two-minute intervals in the mid-clavicular line bilaterally. Additional local anaesthetic solution (5 ml) was administered if a T4 block was not reached after 10 minutes. Arterial blood pressure and pulse rate were measured every three minutes. Hypotension (systolic blood pressure <100 mmHg or >30% decline from baseline) was treated with Hartmann's solution 200 ml and intravenous phenylephrine 50 to 100 µg as per institutional protocol. The primary outcome was the time to surgical readiness, defined as the time from end of injection of epidural solution to loss of cold sensation to T4 bilaterally.
The subjects were regularly encouraged to inform the attending anaesthetist of any intraoperative pain (visual analogue score of 3 or more out of 10) and analgesic supplementation was provided by 50% nitrous oxide with oxygen and intravenous fentanyl 50 to 100 µg. In the event that these measures did not provide adequate anaesthesia, general anaesthesia was to be offered at the discretion of the attending anaesthetist.
The time for loss of sensation to cold to recede by two segments and Bromage score were used to reflect block duration. Data on Apgar scores, need for intraoperative analgesic supplementation, the incidence of hypotension, the incidence of intraoperative vomiting (treated with intravenous ondansetron 4 mg over two minutes if more than two episodes of vomiting occurred in the absence of hypotension), intraoperative shivering (defined as muscular activity in at least one muscle group) 7 and intraoperative pruritus (self-reported) were recorded. The dose of phenylephrine and total intraoperative fluid volume administered were noted.
The sample size calculation was based on data published previously by Lucas et al 8 . These investigators studied 90 patients to compare the time to T4 loss of sensation to cold (30 patients in three groups). A one-third difference in the time required to establish anaesthesia between the lignocaine and the other groups was considered clinically important. Therefore, 30 patients per group were required (alpha 0.05 and power 80%). Data were compared across the three groups using analysis of variance for interval data, Kruskal-Wallis test for ordinal data and the Chi-squared test for dichotomous data, with post hoc Bonferroni's correction. Pair-wise comparisons were performed using t-tests for interval data, Mann-Whitney tests for ordinal data and Chisquared tests for dichotomous data. P values of <0.05 were considered statistically significant.
RESULTS
We approached 251 subjects who requested labour analgesia with combined spinal-epidural analgesia, and 238 subjects consented to take part. Among these parturients, urgent caesarean section was performed in 90 and these women were randomly assigned to a study group. There were no withdrawals or conversions to general anaesthesia. All 90 subjects achieved surgical readiness by 20 minutes. There were no differences between groups for baseline subject characteristics ( Table 1) or preexisting epidural analgesia characteristics ( Table 2) .
Details of epidural anaesthesia are shown in Table 3 . There were no differences between groups in the time to surgical readiness. Ropivacaine and levobupivacaine groups required a similar volume of local anaesthetic before surgery to the LAF group. There was no difference between groups in the need for supplementation with intravenous fentanyl during surgery. No Entonox (50% oxygen and 50% nitrous oxide) or additional local anaesthetic was administered during surgery. The median, interquartile range time for dermatomal block to cold to recede by two segments was longer in the 0.5% levobupivacaine group (155, 127 to 170 minutes) compared with LAF (120, 100 to 150 minutes) (P=0.001), however there was no difference between the 0.75% ropivacaine (143, 110 to 171 minutes) and LAF groups. There was no significant difference in the incidence of intraoperative vomiting (LAF 20.0% vs. 0.75% ropivacaine 20.0% and 0.5% levobupivacaine 23.3%). There was also no significant difference in the incidence of intraoperative shivering (LAF 53% vs. 0.75% ropivacaine 53% and 0.5% levobupivacaine 60%). No patient reported intraoperative pruritus.
There were no significant differences between groups in the intraoperative fluid requirements or incidence of hypotension. The mean (SD) dose of phenylephrine given did not differ (LAF 43 (77) µg vs. 0.75% ropivacaine 50 (78) µg and 0.5% levobupivacaine 30 (60) µg). All neonates had Apgar scores of more than 7 at one and five minutes.
DISCUSSION
We found no significant difference in the time to T4 loss of sensation to cold or to skin incision in our population when comparing LAF with 0.75% ropivacaine and 0.5% levobupivacaine. Lucas et al 8 showed that no variable can predict time to T4 block when extending epidural analgesia for urgent caesarean section. In our study all parturients achieved a T4 block by 20 minutes, which is similar to the results from other studies 8,9 . Pan et al 10 found that 93.5% of caesarean sections were performed under regional anaesthesia and 41% of pre-existing labour epidural catheters were used for caesarean section, reflecting the common practice of extending block in the presence of a functioning epidural catheter. We were careful to exclude parturients with recurrent breakthrough pain and those with recent intrapartum epidural supplementation, because these cases have been associated with a higher risk of failure to adequately extend labour analgesia 11 . Bupivacaine and levobupivacaine were found to have similar potency in both in vitro and in vivo studies 12, 13 . goring-Morris et al 4 found no difference in the time to surgical readiness between LAF and 0.5% bupivacaine. They also reported no conversion to general anaesthesia or difference in the need for intraoperative supplementation. Our study found that there was no significant difference in the time to surgical readiness between LAF and 0.5% levobupivacaine, which is consistent with levobupivacaine and bupivacaine sharing similar potency and characteristics. Bupivacaine has four times the potency of lignocaine 14 . Levobupivacaine, the S(-)-enantiomer of bupivacaine, has a good safety profile, with lower central nervous and cardiovascular system toxicity than bupivacaine but similar clinical characteristics [15] [16] [17] [18] [19] . However, the sensory block duration was 23 to 45 minutes longer with levobupivacaine compared with bupivacaine, a potential advantage if surgery is expected to be prolonged 17 . The 0.5% levobupivacaine group also had a longer duration of sensory block than the LAF group, which supports previous research.
Ropivacaine has two-thirds the potency of bupivacaine and levobupivacaine 20, 21 . Ropivacaine 0.75% did not significantly differ from LAF or 0.5% bupivacaine for the time to surgical readiness in this study and the intraoperative analgesic requirement was similar across groups. Two other studies also found a similar incidence of supplementation between 0.75% ropivacaine and 0.5% bupivacaine at elective caesarean section 22, 23 , but despite the apparent equipotency of epidural 0.75% ropivacaine and 0.5% bupivacaine 24 , Sanders et al 5 noted a lower supplementation rate than 0.5% bupivacaine.
The administration of 15 ml of local anaesthetic solution was based on the average volume given in previous studies of similar nature 5, 9, 25 . Lucas et al 8 reported three women with cervical sensory block in their lignocaine with adrenaline group, so a smaller initial top-up volume may be prudent. In contrast, Lam et al 25 used 15 ml of 2% lignocaine with adrenaline and fentanyl to rapidly extend epidural analgesia for emergency caesarean section, with no cases of cervical sensory block. If a more rapid onset of epidural anaesthesia is required for severe non-reassuring fetal status, alkalinisation of the solution might result in more rapid onset and denser blockade 1 .
The advantage of using a single drug, such as ropivacaine or levobupivacaine, is the potential for fewer drug errors and a shorter solution preparation time. Lucas et al found that preparation time for an epidural bupivacaine solution was approximately half that of a lignocaine with fresh adrenaline solution 26 and were of the opinion that the difference might be clinically significant for an emergency case. However, an additional preparation time of a few minutes may not always be relevant, since not all urgent cases require immediate delivery. Malhotra et al 27 suggested a neuraxial opioid like fentanyl was not required when extending the effects of fentanylcontaining epidural labour analgesia solutions. Their study reported a similar incidence of intraoperative vomiting and intraoperative shivering to our study. goring-Moris et al reported a similar incidence of intraoperative vomiting when 0.5% bupivacaine and LAF were used 4 . However, Paech found less shivering with 0.5% bupivacaine with adrenaline compared with 2% lignocaine with adrenaline 28 .
Difficulties in conducting a study such as this include uncertainty about the timing of urgent caesarean section, which may occur during outof-office hours, the time pressure associated with a requirement for urgent delivery and presence of confounding factors. We used blinding of the parturient and attending clinician, standardisation of the protocol and predefined endpoints to reduce bias. Loss of sensation to cold to assess the block height was used for ease of assessment and the assessment of the block height was standardised to two-minute intervals to increase the precision of assessment. Recent evidence indicates that loss of sensation to touch may be a more reliable block assessment method 29 . Although the sample size of the study is small, the difference in time to surgical readiness was within two minutes, a difference we believe is clinically unimportant. The results of this study cannot be extrapolated to life-threatening emergency caesarean section, where general anaesthesia may be necessary 30 .
In conclusion, the time to surgical readiness did not significantly differ when using LAF, 0.75% ropivacaine and 0.5% levobupivacaine to extend a pre-existing labour analgesic block. A single drug such as ropivacaine or levobupivacaine provided adequate surgical anaesthesia and may reduce the potential for mistakes in preparing drug mixtures 4 . Ropivacaine 0.75% and 0.5% levobupivacaine are suitable alternatives for extending labour analgesia for urgent caesarean section.
